Jasmine Kaur

In adults having chest pain, ST-segment elevation, both benign and pathologic, is a common finding seen on electrocardiograms (ECGs). Some degree of ST-segment elevation is common, especially in young men. Commonly referred to as benign early repolarization (BER), this elevation is seen in the precordial leads. Due to the prevalence of this finding, it is not a normal variant, but rather a normal finding. Here is an unusual case of acute myocardial infarction (MI) presenting as BER. In this case, the ECG did not show typical ST elevation or evolve over time, showing changes of Q waves as expected with ST-segment elevation myocardial infarction. However, the point-of-care troponin was elevated, and the patient was then diagnosed as having acute MI.

University placements can feel like a marathon you never signed up for. Between managing coursework, part-time jobs, and personal responsibilities, adding hundreds of unpaid hours to your schedule can feel almost impossible. I just finished my 600-hour social work placement, and I'll admit, there were moments when I questioned everything, from time management skills to career choice.

This study presents a method for the preparation of polymeric adsorbents which involves the simultaneous radiation-induced grafting of glycidyl methacrylate onto Polyamide 6 fibres (GMA-g-PA6), follo...

Extracorporeal carbon dioxide removal (ECCO₂R) has emerged as a supportive therapy for patients with acute respiratory failure, particularly when refractory hypercapnia and respiratory acidosis persist despite standard management. This narrative review summarizes the physiological rationale, current evidence, and clinical applications of ECCO₂R in modern critical care practice. ECCO₂R removes carbon dioxide directly from the bloodstream, thereby facilitating lung-protective ventilation strategies and potentially reducing ventilator-induced lung injury. The technique has been primarily evaluated in patients with acute respiratory distress syndrome (ARDS) and acute exacerbations of chronic obstructive pulmonary disease (AECOPD). In these settings, ECCO₂R may enable the use of lower tidal volumes and reduced airway pressures, and in selected patients, it may decrease the need for invasive mechanical ventilation. Although ECCO₂R has been shown to improve carbon dioxide clearance, correct respiratory acidosis, and optimize ventilatory parameters, randomized trials have not demonstrated a definitive mortality benefit. Its clinical application is also limited by device-related complications, including bleeding, thrombosis, and hemolysis. Furthermore, outcomes are influenced by technical factors such as cannula configuration, blood flow rate, membrane efficiency, and anticoagulation strategy. Ongoing technological advancements and well-designed clinical trials are needed to better define the role of ECCO₂R in contemporary critical care practice.